Back
Sep 29
Education

EDU 23 - Molecular Intelligence in Breast Cancer Radiation Therapy

10:45am - 12:00pm PT

MODERATOR(S)

Youssef Zeidan, MD, PhD - Department of Radiation Oncology, Florida International University

session DESCRIPTION

Molecular testing is an integral component of multidisciplinary management of breast cancer. Recent evidence underscores the importance of molecular assays in radiation therapy decision making. In addition to their prognostic and predictive benefits, such assays are increasingly utilized for escalation or de-escalation of radiation therapy. The current session will review emerging evidence supporting the use of molecular tests in early stage in-situ and invasive breast cancer. Current and future clinical trials on the topic will be presented.

learning objectives

  1. Assess the utility of molecular tests in radiotherapy decision making.
  2. Discuss the prognostic and predictive impact of molecular tests in early stage breast cancer.

Credits

AMA PRA Category 1 Credits: 1.25

Presentations